Manic Fringe antibody
Quick Overview for Manic Fringe antibody (ABIN7183808)
Target
See all Manic Fringe (MFNG) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Cross-Reactivity
- Human
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from internal of Human MFNG.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB:1:500-1:3000,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Manic Fringe (MFNG) (MFNG)
-
Alternative Name
- MFNG
-
Background
-
Background: Glycosyltransferase involved in the elongation of O-linked ligands to activate Notch signaling. Possesses fucose-specific beta-1,3-N-acetylglucosaminyltransferase activity.
Johnston S.H., Development 124:2245-2254(1997).
Collins J.E., Genome Biol. 5:R84.1-R84.11(2004).
Dunham I., Nature 402:489-495(1999).Aliases: 3-N-acetylglucosaminyltransferase manic fringe antibody, Beta-1 antibody, Beta-1,3-N-acetylglucosaminyltransferase manic fringe antibody, MFNG antibody, MFNG_HUMAN antibody, O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase antibody
-
UniProt
- O00587
-
Pathways
- Notch Signaling
Target
-